Erratum: Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice (Molecular Neurodegeneration (2013) 8:26)

Katherine D. Laclair; Kebreten F. Manaye; Dexter L. Lee; Joanne S. Allard; Alena V. Savonenko; Juan C. Troncoso; Philip C. Wong

doi:10.1186/1750-1326-8-26

Erratum: Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice (Molecular Neurodegeneration (2013) 8:26)

Katherine D. Laclair, Kebreten F. Manaye, Dexter L. Lee, Joanne S. Allard, Alena V. Savonenko, Juan C. Troncoso, Philip C. Wong

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Article number	26
Journal	Molecular neurodegeneration
Volume	8
Issue number	1
DOIs	https://doi.org/10.1186/1750-1326-8-26
State	Published - 2013

ASJC Scopus subject areas

Molecular Biology
Clinical Neurology
Cellular and Molecular Neuroscience

Access to Document

10.1186/1750-1326-8-26

Cite this

Laclair, K. D., Manaye, K. F., Lee, D. L., Allard, J. S., Savonenko, A. V., Troncoso, J. C., & Wong, P. C. (2013). Erratum: Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice (Molecular Neurodegeneration (2013) 8:26). Molecular neurodegeneration, 8(1), Article 26. https://doi.org/10.1186/1750-1326-8-26

Erratum: Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice (Molecular Neurodegeneration (2013) 8:26). / Laclair, Katherine D.; Manaye, Kebreten F.; Lee, Dexter L. et al.
In: Molecular neurodegeneration, Vol. 8, No. 1, 26, 2013.

Research output: Contribution to journal › Comment/debate › peer-review

@article{eef4595305bf4069bb2e20d0f4f95773,

title = "Erratum: Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice (Molecular Neurodegeneration (2013) 8:26)",

author = "Laclair, {Katherine D.} and Manaye, {Kebreten F.} and Lee, {Dexter L.} and Allard, {Joanne S.} and Savonenko, {Alena V.} and Troncoso, {Juan C.} and Wong, {Philip C.}",

year = "2013",

doi = "10.1186/1750-1326-8-26",

language = "English (US)",

volume = "8",

journal = "Molecular neurodegeneration",

issn = "1750-1326",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice (Molecular Neurodegeneration (2013) 8:26)

AU - Laclair, Katherine D.

AU - Manaye, Kebreten F.

AU - Lee, Dexter L.

AU - Allard, Joanne S.

AU - Savonenko, Alena V.

AU - Troncoso, Juan C.

AU - Wong, Philip C.

PY - 2013

Y1 - 2013

UR - http://www.scopus.com/inward/record.url?scp=84888011790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888011790&partnerID=8YFLogxK

U2 - 10.1186/1750-1326-8-26

DO - 10.1186/1750-1326-8-26

M3 - Comment/debate

AN - SCOPUS:84888011790

SN - 1750-1326

VL - 8

JO - Molecular neurodegeneration

JF - Molecular neurodegeneration

IS - 1

M1 - 26

ER -

Erratum: Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice (Molecular Neurodegeneration (2013) 8:26)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this